Fucosylation of serum glycoproteins in lung cancer patients

Clinical Chemistry and Laboratory Medicine

Volumn 43, Issue 4, 2005, Pages 361-369

  Kossowska, Barbara ^a   Ferens Sieczkowska, Mirosława ^a   Gancarz, Roman ^b   Passowicz Muszyńska, Ewa ^a   Jankowska, Renata ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Aleuria aurantia lectin; Carbohydrate ligands; Fucosylation; Lung cancer; Metastasis

Indexed keywords

BIOLOGICAL MARKER; FUCOSE; GLYCAN DERIVATIVE; GLYCOPROTEIN; HAPTOGLOBIN; OLIGOSACCHARIDE; OROSOMUCOID; PLANT LECTIN; PYROXYLIN; LECTIN; LECTIN, ALEURIA AURANTIA; PLASMA PROTEIN; TUMOR MARKER;

ARTICLE; CALCULATION; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DENSITOMETRY; FUCOSYLATION; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; BLOOD; CANCER STAGING; LUNG TUMOR; PREDICTION AND FORECASTING; REFERENCE VALUE;

ALEURIA AURANTIA;

BLOOD PROTEINS; CLUSTER ANALYSIS; FUCOSE; GLYCOPROTEINS; HUMANS; LECTINS; LUNG NEOPLASMS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; TUMOR MARKERS, BIOLOGICAL;

EID: 24044509833     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2005.066     Document Type: Article

References (40)

1. Ørntoft TF, Vestergaard EM. Clinical aspects of altered glycosylation of glycoproteins in cancer. Electrophoresis 1999;20:362-71.
2. Gabius H-J, Andréy S, Kaltner H, Siebert H-C. The sugar code: functional lectinomics. Biochim Biophys Acta 2002;1572:165-77.
3. O'Donnell N. Intracellular glycosylation and development. Biochim Biophys Acta 2002;1573:336-45.
4. Marquardt T, Denecke J. Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies. Eur J Pediatr 2003;162:359-79.
5. Hakomori S. Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci USA 2002;99:10231-3.
6. Lowe JB. Glycosylation, immunity and autoimmunity. Cell 2001;104:809-12.
7. Miyagi T, Wada T, Yamaguchi K, Hata K. Sialidase and malignancy: a minireview. Glycoconj J 2004;20:189-98.
8. Becker DJ, Lowe JB. Fucose: biosynthesis and biological functions in mammals. Glycobiology 2003;13:41R-53R.
9. Sturla L, Rampal R, Haltiwanger RS, Fruscione F, Etzioni A, Tonetti M. Differential terminal fucosylation of N-linked glycans versus protein O-fucosylation in leukocyte adhesion deficiency type II (CDG IIc). J Biol Chem 2003;278:26727-33.
10. Nangia-Makker P, Conklin J, Hogan V, Raz A. Carbohydrate-binding proteins in cancer, and their ligands as therapeutic agents. Trends Mol Med 2002;8:187-92.
11. Kannagi R, Izawa M, Koike T, Miyazaki K, Kimura N. Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci 2004;95:377-84.
12. Kannagi R. Regulatory roles of carbohydrate ligands for selectins in the homing of lymphocytes. Curr Opin Struct Biol 2002;12:599-608.
13. Yamazaki N, Kojima S, Bovin NV, André S, Gabius S, Gabius H-J. Endogenous lectins as targets for drug delivery. Adv Drug Deliv Rev 2000;43:225-44.
14. Kaila N, Thomas BE, Thakker P, Alvarez JC, Camphausen RT, Crommie D. Design and synthesis of sialyl Lewis X mimics as E-selectin inhibitors. Bioorg Med Chem Lett 2001;11:151-5.
15. Chervin SM, Lowe JB, Koreeda M. Synthesis and biological evaluation of a new sialyl Lewis X mimetic derived from lactose. J Org Chem 2002;67:5654-62.
16. Turner GA. N-glycosylation of serum proteins in disease and its investigation using lectins. Clin Chim Acta 1992;208:149-71.
17. 1-acid glycoprotein (orosomucoid) in human sera. J Exp Med 1993; 177:657-66.
18. 1-acid glycoprotein (orosomucoid) in health and disease: occurrence, regulation and possible functional implications. Trends Glycosci Glycotechnol 1998;10:235-45.
19. 1-acid glycoprotein (orosomukoid) compared with traditional biochemical markers of inflammation in recent onset rheumatoid arthritis. Clin Chim Acta 2002;317:221-9.
20. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
21. Merril CR, Goldman D, Sedman SA, Ebert MH. Ultrasensitive stain for proteins in polyacrylamide gels show variation in cerebrospinal fluid proteins. Science 1981;211:1437-8.
22. Towbin H, Stachelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-3.
23. Yamashita K, Kochibe N, Ohkura T, Ueda I, Kobata A. Fractionation of L-fucose containing oligosaccharides on immobilized Aleuria aurantia lectin. J Biol Chem 1985;260:4688-93.
24. 1-acid glycoprotein fucosylation in the acute phase response. Clin Chem 1999;45:2010-2.
25. Strouf O. Chemical pattern recognition. Letchworth: Research Studies Press, 1986.
26. Borsig L, Wong R, Hynes RO, Varki NM, Varki A. Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc Natl Acad Sci USA 2002;99:2193-8.
27. Okuno K, Kawai I, Hirai N, Narimatsu H, Yasutomi M. Role of sialyl Lewis X in liver metastasis in view of liver-associated immunity. Hepatogastroenterology 2003; 50:756-60.
28. Zipin A, Israeli-Amit M, Meshel T, Sagi-Assif O, Yron I, Lifshitz V, et al. Tumor-microenvironment interactions: the fucose-generating FX enzyme controls adhesive properties of colorectal cancer cells. Cancer Res 2004;64:6571-8.
29. Brown JR, Fuster MM, Whisenant T, Esko JD. Expression patterns of α2,3-sialyltransferase and α1,3-fucosyltransferase determine the mode of sialyl Lewis X inhibition by disaccharide decoys. J Biol Chem 2003;278:23352-9.
30. Kim YJ, Varki A. Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconj J 1997;14:569-76.
31. Nakagoe T, Sawai T, Tsuji T, Jibiki M-A, Nanashima A, Yamaguchi H, et al. Predictive factors for preoperative serum levels of sialyl Lewis X, sialyl Lewis A and sialyl Tn antigens in gastric cancer patients. Anticancer Res 2002;22:451-8.
32. Sumikura S, Ishigami S, Natsugoe S, Miyazono F, Tokuda K, Nakajo A, et al. Disseminated cancer cells in the blood and expression of sialylated antigen in gastric cancer. Cancer Lett 2003;200:77-83.
33. Dargan E, Thompson S, Cantwell MJ, Wilson RG, Turner GA. Changes in the fucose content of haptoglobin in breast and ovarian cancer: association with disease progression. Glycosyl Disease 1994;1:37-43.
34. Otake Y, Fujimoto I, Tanaka F, Nakagawa T, Ikeda T, Menon KK, et al. Isolation and characterization of an N-linked oligosaccharide that is significantly increased in sera from patients with non-small cell lung cancer. J Biochem 2001;129:537-42.
35. Satoh H, Ishikawa H, Kamma H, Yamashita YT, Takahashi H, Ohtsuka M, et al. Serum sialyl Lewis X-I antigen levels in non-small cell lung cancer: correlation with distant metastasis and survival. Clin Cancer Res 1997;3:495-9.
36. Satoh H, Ishikawa H, Yamashita YT, Ohtsuka M, Sekizawa K. Serum sialyl Lewis X-i antigen in lung adenocarcinoma and idiopathic pulmonary fibrosis. Thorax 2002;57:263-6.
37. Binz PA, Hochstrasser DF, Appel RD. Mass spectrometry-based proteomics: current status and potential use in clinical chemistry. Clin Chem Lab Med 2003;41:1540-51.
38. Clarke W, Zhang Z, Chan DW. The application of clinical proteomics to cancer and other diseases. Clin Chem Lab Med 2003;41:1562-70.
39. Moldway J, Scheid P, Wild P, Nabil K, Siat j, Borrelly J, et al. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma. Clin Cancer Res 2000;6:1125-34.
40. Trapé J, Buxo J, de Olaguer JP, Vidal C. Tumor markers as prognostic factors in treated non-small cell lung cancer. Anticancer Res 2003;23:4277-82.